Study confirms redmesivir shortens Covid recovery by 2 days
The antiviral remdesivier cuts recovery time by about two days, but does not reduce the risk of dying from of the infection, a new study suggests. Remdesivir is the only therapeutic drug approved for emergency use to treat COVID-19 in the U.S., but clinical trials sponsored by the National Institutes of Health and the World … Read more